Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pRxhVEGFbsr (#RDB03986)

Retroviral vector of human VEGF

Clone info. Retroviral vector of human VEGF (vascular endothelial cell growth factor).
Comment Expression was confirmed by depositor with ELISA.
Vector backbone Plasmid
Selectable markers Amp^r (E. coli), bsr (mammalian cell)
Gene/insert name Human VEGF cDNA
Depositor|Developer Hamada, Hirofumi |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.(J. Gene Med., 5, 900-908 (2003); J. Gene Med., 5, 994-1004 (2003).) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Remarks Remember that you will be working with samples containing infectious virus.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(J. Gene Med., 5, 900-908 (2003); J. Gene Med., 5, 994-1004 (2003).)。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。
備考 このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。

Catalog # Resource name Availability Shipping form Fee (non-profit org.)
RDB03986 pRxhVEGFbsr Under QC test. Please contact us. DNA solution Please contact us.

check Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.

How to cite this biological resource

Materials & Methods section:

The pRxhVEGFbsr was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB03986).

Reference section:

Huang, J., Ito, Y., Kobune, M., Sasaki, K., Nakamura, K., Dehari, H., Takahashi, K., Ikeda, K., Uchida, H., Kato, K., Hamada, H., Myocardial injection of CA promoter-based plasmid mediates efficient transgene expression in rat heart. J. Gene Med., 5, 900-908 (2003). PMID 14533199. [link to RRC of NBRP]
Yamauchi, A., Ito, Y., Morikawa, M., Kobune, M., Huang, J., Sasaki, K., Takahashi, K., Nakamura, K., Dehari, H., Niitsu, Y., Abe, T., Hamada, H., Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J. Gene Med., 5, 994-1004 (2003). PMID 14601137. [link to RRC of NBRP]

Further references such as user reports and related articles (go to bottom)

QC test results

check Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.

References

Original, user report and related articles

original Huang, J., Myocardial injection of CA promoter-based plasmid mediates efficient transgene expression in rat heart. J. Gene Med., 5, 900-908 (2003). PMID 14533199. [link to RRC of NBRP]
original Yamauchi, A., Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J. Gene Med., 5, 994-1004 (2003). PMID 14601137. [link to RRC of NBRP]
reference Wakimoto, H., Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy. Jpn. J. Cancer Res., 88, 296-305 (1997). PMID 9140115.